# A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes

> **NCT00260065** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 99 (actual)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT00260065
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-06
- **Final completion:** 2008-12
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2013-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00260065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00260065, "A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00260065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*